Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
READY-ICH
NCT07695220Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Dec 2026
- Primary completion
- Oct 2028
01
Overview
Randomised, open-label trial of remifentanil and dexmedetomidine in intracerebral hemorrhage (ICH) (2 arms), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoint: Modified Rankin Scale at 90 days. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
remifentanildexmedetomidine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07695220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07695220.